• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Malaysia·Basic Materials·4148.TW
Share

All Cosmos Bio-Tech Holding Corporation Stocks

NT$ 31.6Last Updated 14.10.2026

Issuer Rating

4/7
Performance

Favourable

Risk

Considerable

Recommendation

Hold

Market Cap

NT$ 67.32M

NT$ 31.6
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Weak growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

All Cosmos Bio-Tech Holding Corporation, through its various operating units, primarily focuses on the production and distribution of bio-organic and bio-chemical compound fertilizers across Malaysia. The company also dedicates efforts to the research and development of microorganisms, particularly for the sustainable management of oil palm waste. Furthermore, it engages in the bulk supply of probiotics. Its activities extend to forest management and associated research initiatives. Internationally, All Cosmos Bio-Tech exports its various offerings to markets including Taiwan, Indonesia, Vietnam, and China. The corporation was established in 1999 and maintains its head office in George Town, Cayman Islands.

Company Valuation

Slightly undervalued
5/7

Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. In particular, the stock is reasonably priced on P/E, 'cheap' on

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

14.10.2026 23:19

Nebius shares plummeted 10%, and CoreWeave shares fell 17% amid forecasts of risks to the sector

14.10.2026 22:53

Nasdaq's decline accelerated to 2% amid inflation data and a sell-off in chipmakers

14.10.2026 22:42

"Until it hits home": How Wall Street Reacted to the New Inflation Data

14.10.2026 22:25

Apple's market capitalization has once again surpassed the $5 trillion mark. Is it too late to buy shares?

14.10.2026 22:09

BofA stock heads for worst day since April 2025

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026